Stefan Deneberg

1.5k total citations
26 papers, 782 citations indexed

About

Stefan Deneberg is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Stefan Deneberg has authored 26 papers receiving a total of 782 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hematology, 14 papers in Molecular Biology and 6 papers in Genetics. Recurrent topics in Stefan Deneberg's work include Acute Myeloid Leukemia Research (21 papers), Epigenetics and DNA Methylation (7 papers) and Acute Lymphoblastic Leukemia research (6 papers). Stefan Deneberg is often cited by papers focused on Acute Myeloid Leukemia Research (21 papers), Epigenetics and DNA Methylation (7 papers) and Acute Lymphoblastic Leukemia research (6 papers). Stefan Deneberg collaborates with scholars based in Sweden, Germany and United States. Stefan Deneberg's co-authors include Sören Lehmann, Martin Höglund, Lars Möllgård, Lovisa Wennström, Sofia Bengtzén, Gunnar Juliusson, Hareth Nahi, Christer Paul, Mohsen Karimi and Sylvain Lehmann and has published in prestigious journals such as Blood, Leukemia and Haematologica.

In The Last Decade

Stefan Deneberg

25 papers receiving 772 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stefan Deneberg Sweden 13 596 560 125 109 103 26 782
Lovisa Wennström Sweden 11 385 0.6× 618 1.1× 170 1.4× 192 1.8× 29 0.3× 24 687
Serena Lavorgna Italy 16 504 0.8× 484 0.9× 118 0.9× 144 1.3× 171 1.7× 30 771
Tianna Dauses United States 6 318 0.5× 483 0.9× 184 1.5× 89 0.8× 37 0.4× 8 630
C.C So China 13 184 0.3× 272 0.5× 189 1.5× 40 0.4× 36 0.3× 36 482
Emiliano Fabiani Italy 18 419 0.7× 444 0.8× 184 1.5× 96 0.9× 77 0.7× 48 695
Tadasu Tobita Japan 10 213 0.4× 206 0.4× 66 0.5× 61 0.6× 8 0.1× 12 381
Tetsuichi Yoshizato Japan 10 201 0.3× 312 0.6× 131 1.0× 15 0.1× 62 0.6× 29 476
Denise Levitan United States 8 331 0.6× 229 0.4× 33 0.3× 106 1.0× 83 0.8× 18 546
Maoxiang Qian China 11 315 0.5× 189 0.3× 18 0.1× 93 0.9× 93 0.9× 43 516
P. Flynn United States 6 178 0.3× 135 0.2× 35 0.3× 56 0.5× 29 0.3× 12 320

Countries citing papers authored by Stefan Deneberg

Since Specialization
Citations

This map shows the geographic impact of Stefan Deneberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Deneberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Deneberg more than expected).

Fields of papers citing papers by Stefan Deneberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefan Deneberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Deneberg. The network helps show where Stefan Deneberg may publish in the future.

Co-authorship network of co-authors of Stefan Deneberg

This figure shows the co-authorship network connecting the top 25 collaborators of Stefan Deneberg. A scholar is included among the top collaborators of Stefan Deneberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefan Deneberg. Stefan Deneberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Deneberg, Stefan, Bertil Uggla, Austin Smith, et al.. (2024). A Phase I/II Study Investigating Karonudib in Patients with Refractory Haematological Malignancies. Blood. 144(Supplement 1). 6010–6010. 1 indexed citations
2.
Palmblad, Jan, Ebba Sohlberg, Christer Nilsson, et al.. (2023). Clinical and immunological features in ACKR1/DARC-associated neutropenia. Blood Advances. 8(3). 571–580. 3 indexed citations
3.
Landtblom, Anna Ravn, et al.. (2023). Omalizumab alleviates pruritus in myeloproliferative neoplasms. Haematologica. 108(7). 1968–1971. 1 indexed citations
4.
Eriksson, Anna, Martin Jädersten, Vladimir Lazarević, et al.. (2022). A risk score based on real-world data to predict early death in acute promyelocytic leukemia. Haematologica. 107(7). 1528–1537. 12 indexed citations
5.
Nilsson, Christer, Erik Hulegårdh, Hege Garelius, et al.. (2022). Characterization of therapy-related acute myeloid leukemia: increasing incidence and prognostic implications. Haematologica. 108(4). 1015–1025. 21 indexed citations
6.
Richter, Johan, Anna Lübking, Stina Söderlund, et al.. (2021). Molecular status 36 months after TKI discontinuation in CML is highly predictive for subsequent loss of MMR—final report from AFTER-SKI. Leukemia. 35(8). 2416–2418. 16 indexed citations
7.
Juliusson, Gunnar, Martin Jädersten, Stefan Deneberg, et al.. (2020). The prognostic impact of FLT3-ITD and NPM1 mutation in adult AML is age-dependent in the population-based setting. Blood Advances. 4(6). 1094–1101. 47 indexed citations
8.
Lehmann, Sören, Stefan Deneberg, P Antunović, et al.. (2017). Early death rates remain high in high-risk APL: update from the Swedish Acute Leukemia Registry 1997–2013. Leukemia. 31(6). 1457–1459. 40 indexed citations
9.
Lazarević, Vladimir, Aldana Rosso, Gunnar Juliusson, et al.. (2017). Incidence and prognostic significance of isolated trisomies in adult acute myeloid leukemia: A population‐based study from the Swedish AML registry. European Journal Of Haematology. 98(5). 493–500. 10 indexed citations
10.
Qu, Ying, Andreas Lennartsson, Verena I. Gaidzik, et al.. (2014). Differential methylation in CN-AML preferentially targets non-CGI regions and is dictated byDNMT3Amutational status and associated with predominant hypomethylation of HOX genes. Epigenetics. 9(8). 1108–1119. 65 indexed citations
11.
Deneberg, Stefan, Meena Kanduri, Dina Ali, et al.. (2014). microRNA-34b/con chromosome 11q23 is aberrantly methylated in chronic lymphocytic leukemia. Epigenetics. 9(6). 910–917. 42 indexed citations
12.
Deneberg, Stefan. (2012). Epigenetics in Myeloid Malignancies. Methods in molecular biology. 863. 119–137. 4 indexed citations
13.
Lehmann, Sylvain, Anna Ravn Landtblom, Lotta Höglund Carlsson, et al.. (2011). Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry. Leukemia. 25(7). 1128–1134. 228 indexed citations
14.
Deneberg, Stefan, Philippe Guardiola, Andreas Lennartsson, et al.. (2011). Prognostic DNA methylation patterns in cytogenetically normal acute myeloid leukemia are predefined by stem cell chromatin marks. Blood. 118(20). 5573–5582. 61 indexed citations
15.
Ali, Dina, Stefan Deneberg, Sofia Bengtzén, et al.. (2010). APR-246 exhibits anti-leukemic activity and synergism with conventional chemotherapeutic drugs in acute myeloid leukemia cells. European Journal Of Haematology. 86(3). 206–215. 53 indexed citations
16.
Deneberg, Stefan, Michael Grövdal, Mohsen Karimi, et al.. (2010). Gene-specific and global methylation patterns predict outcome in patients with acute myeloid leukemia. Leukemia. 24(5). 932–941. 101 indexed citations
17.
Uggla, Bertil, Stefan Deneberg, Sofia Bengtzén, et al.. (2009). Low p14ARF expression in de novo acute myeloid leukemia with normal karyotype is associated with poor survival. Leukemia & lymphoma. 50(9). 1512–1518. 4 indexed citations
18.
Akagi, Tadayuki, Lee‐Yung Shih, Seishi Ogawa, et al.. (2009). Single nucleotide polymorphism genomic arrays analysis of t(8;21) acute myeloid leukemia cells. Haematologica. 94(9). 1301–1306. 13 indexed citations
19.
Deneberg, Stefan, R. Lerner, Per Ljungman, Olle Ringdén, & Hans Hägglund. (2007). Relapse of preB-ALL after rituximab treatment for chronic graft versus host disease. Implications for its use?. Medical Oncology. 24(3). 354–356. 4 indexed citations
20.
Möllgård, Lars, Stefan Deneberg, Hareth Nahi, et al.. (2007). The FLT3 inhibitor PKC412 in combination with cytostatic drugs in vitro in acute myeloid leukemia. Cancer Chemotherapy and Pharmacology. 62(3). 439–448. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lovisa Wennström Breakdown of academic impact, for papers by Serena Lavorgna Breakdown of academic impact, for papers by Tianna Dauses Breakdown of academic impact, for papers by C.C So Breakdown of academic impact, for papers by Emiliano Fabiani Breakdown of academic impact, for papers by Tadasu Tobita Breakdown of academic impact, for papers by Tetsuichi Yoshizato Breakdown of academic impact, for papers by Denise Levitan Breakdown of academic impact, for papers by Maoxiang Qian Breakdown of academic impact, for papers by P. Flynn
Rankless by CCL
2026